You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
NO
YES

HIGHLIGHTS

EVENTS

EIGHT, the global educational initiative on Hemophilia A and its treatment

Experts from all over the world attended the EIGHT 2018 Conference in Budapest, Hungary on 12-13 October

read more 

EVENTS

Kedrion Biopharma participates in the Mother and Child Conference in Moscow

A 50 years of Anti-D dedicated programme presented at the main Russian congress of Gynecology and Obstetrics

read more 

EVENTS

Kedrion Joins Annual PNS Conference on Neurology

The company took part in the event with a booth and a delegation of 40 int’l guests

read more 
  1. EVENTS - 15-05-2015

    Kedrion Continues Global Expansion with Dedication Ceremony at US Facility

    Biopharma Company Celebrates with Local Guests and Dignitaries in Melville, New York

    read more 
  2. CORPORATE - 30-04-2015

    Kedrion SpA’s Shareholders approve 2014 financial statement

    A 466 million euros’ turnover with a 9,8% rise on 2013

    read more 
  3. EVENTS - 17-04-2015

    Kedrion supported the XI World Hemophilia Day

    An increasingly tailor-made prophylaxis lets sports and hemorrhagic conditions live together

    read more 

Pages

For more information please contact: pressoffice@kedrion.com